000 | 01956 a2200517 4500 | ||
---|---|---|---|
005 | 20250516121258.0 | ||
264 | 0 | _c20130904 | |
008 | 201309s 0 0 eng d | ||
022 | _a1569-8041 | ||
024 | 7 |
_a10.1093/annonc/mds530 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGonzalez-Angulo, A M | |
245 | 0 | 0 |
_aFunctional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cApr 2013 |
||
300 |
_a909-16 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoadjuvant Therapy |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 | _aProtein Array Analysis |
650 | 0 | 4 | _aProteomics |
650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
700 | 1 | _aLiu, S | |
700 | 1 | _aChen, H | |
700 | 1 | _aChavez-Macgregor, M | |
700 | 1 | _aSahin, A | |
700 | 1 | _aHortobagyi, G N | |
700 | 1 | _aMills, G B | |
700 | 1 | _aDo, K-A | |
700 | 1 | _aMeric-Bernstam, F | |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 24 _gno. 4 _gp. 909-16 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mds530 _zAvailable from publisher's website |
999 |
_c22251840 _d22251840 |